Abstract
Toxoplasma gondii is an opportunistic parasite with avirulent cystogenic and highly virulent non-cystogenic isolates. Although non-cystogenic strains are considered the most virulent, there are also marked genetic and virulence differences among these strains. Excretory-secretory antigens (ESAs) of T. gondii are critical for the invasion process and the immune response of the host. To better understand the differences in virulence between non-cystogenic T. gondii isolates, we studied ESAs of the RH strain (Type I), and the very prevalent in China, but less virulent TgCtwh3 strain (Chinese 1). ESAs of RH and TgCtwh3 triggered different levels of TNF-α production and macrophage M1 polarization. Using iTRAQ analysis, 27 differentially expressed proteins originating from secretory organelles and surface were quantified. Of these proteins, 11 microneme-associated proteins (MICs), 6 rhoptry proteins, 2 dense granule proteins and 5 surface proteins were more abundant in RH than in TgCtwh3. The protein-protein correlation network was employed to identify the important functional node protein MIC3, which was upregulated 5-fold in RH compared with TgCtwh3. MIC3 was experimentally confirmed to evoke a TNF-α secretory response, and it also induced macrophage M1 polarization. This result suggests that MIC3 is a potentially useful immunomodulator that induces TNF-α secretion and macrophage M1 polarization.
Toxoplasma gondii is a successful protozoan parasite that is prevalent worldwide in humans and in many warm-blooded animals. Most infections caused by T. gondii are asymptomatic in humans, but infection acquired during pregnancy may lead to severe congenital toxoplasmosis, and immunosuppressed individuals, including AIDS patients, may suffer severe diseases, including toxoplasmic encephalitis1. In addition to the immune status of the host, the virulence of T. gondii strains also influences clinical outcomes. Cystogenic T. gondii strains form chronic tissue cysts and are usually avirulent. Non-cystogenic isolates tend to be highly virulent in mice, making mice good research models for acute toxoplasmosis.
Non-cystogenic T. gondii strains vary genetically and in terms of virulence. The RH strain (Type I genotype) is a common virulent isolate in North America and Europe, and strain TgCtwh3 (Chinese 1 genotype) is common in China2,3. Previous studies have demonstrated that strain TgCtwh3 is less virulent than strain RH. For example, Li et al.3 found that the average number of survival days post-infection of mice with 10 tachyzoites was 9 days for strain RH and 12 days for strain TgCtwh3. The dose-dependent hazard ratio for mice infected with RH tachyzoites was more than 3-fold higher than that with TgCtwh3 tachyzoites3. However, the underlying molecular reasons for this discrepancy are unclear.
Proteomic techniques offer an excellent platform to investigate T. gondii. Proteomic studies in T. gondii initially focused on the identification of proteins in the total cell extract4,5,6. Modern quantitative proteomics has mainly focused on North American and European T. gondii isolates7,8,9. However, approximately 7.9% of the human population10 and 18.0% of retail pork11 in China tested positive for anti-T. gondii antibodies. The prevalent T. gondii isolates in China differ from the American and European isolates. Zhou et al.12 explored the complete proteomic profile of T. gondii tachyzoites of the Chinese 1 TgC7 strain in comparison to Western isolates and identified several differentially abundant proteins using 2D difference gel electrophoresis (DIGE) combined with matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS). Unfortunately, although there is much data on the total extract of tachyzoites, the specific proteins that are important for T. gondii pathogenicity remains to be determined.
Excretory-secretory antigens (ESAs) produced by T. gondii tachyzoites represent the majority of the circulating antigens in serum and cerebrospinal fluid from hosts with acute infection13,14,15. They are among the first targets of the host cellular and humoral immune response, which limits the infection13,14,15,16,17,18. Most ESAs are secreted from the T. gondii apical organelle complex, consisting of rhoptries, micronemes and dense granules19,20,21. The rhoptry and microneme ESAs promote adherence and host cell invasion19,21. The dense granule proteins are important for the formation of the parasitophorous vacuole (PV), which shields the pathogen from the nitric oxide produced by M1-polarized macrophages for defence against the parasite19. Thus, T. gondii ESAs are important antigens and also play an important role in the invasion process. Hence, targeted studies of ESAs should be conducted to reveal important proteins associated with virulence.
The defensive host reaction against virulent T. gondii involves TNF-α production, and M1 polarization of macrophages, including the induction of the iNOS and IL-6 genes to produce nitric oxide and IL-6, respectively22,23,24. In this study, we reported that the ESAs from the less virulent Chinese 1 TgCtwh3 strain induced lower TNF-α production, and a fewer number of M1 macrophages than the T. gondii Type I RH (Western) strain. We employed isobaric Tags for Relative and Absolute Quantification (iTRAQ) for comparative proteome analysis to identify differentially expressed ESA proteins in the two non-cystogenic, virulent T. gondii strains. Twenty-seven differentially abundant ESA proteins were identified, and five of them were shown to be transcriptionally induced using qPCR. The soluble adhesin, MIC319,25, from the microneme, was 5-fold more abundant in strain RH than in strain TgCtwh3. Pure MIC3 induced TNF-α production and macrophage M1-dominant polarization. Therefore, MIC3 played a very important role in T. gondii virulence. These results highlight additional directions of study to better understand MICs.
Results
Tachyzoites and ESAs of the Chinese 1 TgCtwh3 strain induced lower levels of TNF-α production than those of the Type I RH strain
The virulence of the RH and TgCtwh3 strains has been studied by measuring the survival times of mice inoculated with T. gondii tachyzoites3. However, differences in the host immune responses to these strains have not yet been evaluated. We wanted to elucidate why Chinese 1 TgCtwh3 appeared to be less virulent than the Type I RH strain. Previous studies have demonstrated that TNF-α production is involved in the pathogenesis of toxoplasmosis22. TNF-α reduces T. gondii replication both in vivo and in vitro, but it also causes inflammation26. To compare the level of TNF-α induced after infection with T. gondii strains RH and TgCtwh3, 1 × 106 freshly harvested T. gondii RH or TgCtwh3 tachyzoites, or phosphate buffered saline (PBS) control were intraperitoneally injected into C57BL/6 mice. After 3 days, the levels of TNF-α in mouse serum were 64.24 ± 23.99, 19.08 ± 8.90, and 0.82 ± 0.94 pg/ml for RH, TgCtwh3, and the control, respectively (Fig. 1A). The ratio of TNF-α produced in response to RH and TgCtwh3 was approximately 3-fold, and RH produced significantly more TNF-α than TgCtwh3 (P < 0.001). Therefore, the reported T. gondii dose-dependent hazard ratio3 and the level of TNF-α production seemed to be correlated (r > 0.6, P < 0.05). In addition, we assessed the parasite burden in the spleens of infected mice. On day 3 post-inoculation, the splenic parasite burden was similar in mice that were injected with RH or TgCtwh3 tachyzoites (P > 0.05, Supplementary Fig. S1). This result suggested that the difference in TNF-α production in vivo was not attributed to the growth and replication discrepancy of T. gondii.
To determine whether T. gondii RH tachyzoites can induce higher levels of TNF-α not only in vivo but also in vitro, 1 × 106 freshly harvested T. gondii RH or TgCtwh3 tachyzoites, or PBS controls were added to splenocytes of C57BL/6 mice. After 3 days, the TNF-α levels were 194.84 ± 17.98, 69.37 ± 8.56, and 10.12 ± 4.58 pg/ml for RH, TgCtwh3, and the control, respectively (Fig. 1B). The ratio of TNF-α produced (RH: TgCtwh3) was approximately 3:1, and greater TNF-α production was induced by RH tachyzoites than TgCtwh3 tachyzoites in vitro (P < 0.001).
T. gondii is known to secrete many proteins that are collectively known as ESAs. Some of these proteins are important antigens or are known to be involved in the infection process15. To investigate whether T. gondii ESAs contribute to the discrepancy in TNF-α secretion induced by RH and TgCtwh3 tachyzoites, freshly isolated mouse splenocytes were stimulated with 10 μg/ml RH, TgCtwh3 ESAs (free of endotoxin), or OVA (ovalbumin) control for 3 days, and the TNF-α levels were 446.52 ± 22.86, 112.32 ± 12.67, and 20.36 ± 11.96 pg/ml, respectively (Fig. 1C). RH ESAs induced significantly higher amounts of TNF-α than TgCtwh3 ESAs (P < 0.001). The ratio of TNF-α produced (RH-OVA: TgCtwh3-OVA) was approximately 4:1. Therefore, the differential induction of TNF-α production was similar for mice infected with live T. gondii tachyzoites.
Macrophages are known to secrete TNF-α. We wanted to determine whether the T. gondii ESA preparations could stimulate TNF-α production in vitro in macrophages. Freshly isolated mouse peritoneal macrophages were stimulated with 10 μg/ml RH, TgCtwh3 ESAs, or OVA for 3 days. For peritoneal macrophages, TNF-α production was 1424.46 ± 60.15, 898.28 ± 78.59, and 245.00 ± 41.45 pg/ml for RH ESAs, TgCtwh3 ESAs and OVA, respectively (Fig. 1D). RH ESAs induced significantly more TNF-α than TgCtwh3 ESAs (P < 0.001). The ratio of TNF-α produced (RH-OVA: TgCtwh3-OVA) was approximately 2:1, showing a correlation between the reported T. gondii hazard ratio3 and ESA-induced TNF-α secretion (r > 0.6, P < 0.05). Thus, we decided to focus on T. gondii ESAs to identify the one(s) responsible for the induction of TNF-α secretion in C57BL/6 mice.
Macrophages are necessary for host protection during T. gondii infection27. Acute T. gondii infection initiates M1-dominant polarization of macrophages, which produce high levels of NO and proinflammatory cytokines such as TNF-α and IL-622,23,28,29. M1 macrophages destroy intracellular pathogens by releasing NO, which is known to be a major effector molecule in macrophage-mediated cytotoxicity27. However, an over-production of NO may result in serious immunopathology. In contrast to M1-polarized macrophages, M2-polarized macrophages rarely express inducible nitric oxide synthase (iNOS) but express high levels of arginase 1 (Arg-1), which skews the metabolic pathway of NO to produce proline27. Other genes that are induced by M2 macrophages include IL-10 and Fizz-1 (also called RELM-α)27. To characterize the differentiation of macrophage polarization, qPCR was used to measure the amounts of the above marker genes in peritoneal macrophages 3 days after stimulation with 10 μg/m T. gondii ESAs. Compared with the OVA control, RH ESAs induced iNOS and IL-6 mRNA upregulation more than 13-fold, but Arg-1, IL-10 and Fizz-1 did so less than 4-fold (Fig. 1E). This result suggested that macrophages could change their weak polarization state to a profoundly M1-dominant polarized state in response to RH ESA stimulation. TgCtwh3 ESAs were less effective at inducing iNOS and IL-6. The mRNA for these genes and for Arg-1, IL-10 and Fizz-1 was upregulated less than 4-fold. Thus, T. gondii TgCtwh3 ESAs were less effective than RH ESAs in stimulating TNF-α production and macrophage M1 polarization.
We also analysed the expression of selected cell surface markers, CD16/32, CD206, F4/80 and CD11b, using flow cytometry (FCM), to characterize peritoneal macrophage polarization (Fig. 1F). The cells expressing CD16/32+F4/80+CD11b+ or CD206+F4/80+CD11b+ were defined as M1 or M2 macrophages, respectively. M1 macrophages were the predominant macrophages in both the RH ESA group and the TgCtwh3 ESA group. Compared with the OVA control, the percentage of M1 macrophages significantly increased after stimulation with RH ESAs (P < 0.001). TgCtwh3 ESAs were less effective than RH ESAs at inducing CD16/32 expression (P < 0.01). However, the percentage of M2 macrophages did not show any significant differences in OVA and ESA groups. This result further indicated that RH ESAs were more effective than TgCtwh3 ESAs at inducing M1-dominant polarized state.
Overview of the proteomic analysis of ESA proteins
A quantitative iTRAQ-LC-MS/MS proteomics approach was employed herein to assess differences between the amounts of ESA proteins produced by strains RH and TgCtwh3 (Supplementary Fig. S2). Two independent cultivations of both the RH and TgCtwh3 strain were used, resulting in two biological replicates for each strain.
The raw data were filtered to eliminate low-scoring spectra, and the qualified spectra were matched to 984 T. gondii proteins (Fig. 2A). A total of 301,033 spectra were obtained. We identified 8,168 spectra, among which 7,579 were unique. Analytical results using the Mascot 2.3.02 search engine resulted in the acquisition of 3,699 T. gondii peptides, which included 3,578 unique peptides representing 984 T. gondii proteins. The protein mass distribution >10 kDa followed a normal distribution (Fig. 2B) as follows: 0–50 kDa, 39.1%; 50–100 kDa, 36.3%; and >100 kDa, 24.6%. Three hundred fifty-eight proteins were represented by only a single peptide, which was not considered sufficient for the reliable identification of a protein, and these proteins were not used in further analyses. Six hundred twenty-six ESA proteins that were represented by two or more peptides, were further assessed (Fig. 2C). The distribution of protein sequence coverage is shown in Fig. 2D. Protein sequence coverage representing less than 10%, 10–20%, 20–30%, 30–40%, and 40–100% variation accounted for 60.97%, 22.26%, 9.35%, 3.66%, and 3.76% coverage, respectively.
The reproducibility of the quantitative proteomic analyses was assessed by comparing the two biological replicates from each strain. The difference was plotted versus the percentage of proteins identified. The results showed that 80% of the proteins had a delta error difference of less than 0.15–0.25, and more than 95% of the proteins had a delta error difference of less than 0.5, suggesting that the biological noise was reasonably low (Supplementary Fig. S3).
Functional categories of differentially expressed proteins
Greater than 1.2-fold differences between the amounts of proteins observed in the ESAs of T. gondii strains RH and TgCtwh3 were considered significant (P < 0.05). Smaller differences were ignored. The iTRAQ analytical results revealed 48 proteins that were more abundant and 18 proteins that were less abundant in the ESAs of T. gondii strain RH than in strain TgCtwh3. Detailed information is provided for each protein in Supplementary Table S1. Twenty-one of the 66 differentially abundant ESA proteins originated from T. gondii secretory organelles (microneme, rhoptry, and dense granule), and 6 were from the T. gondii cell surface (Table 1, Fig. 3). The vast majority of the 27 known secretory or surface proteins were highly expressed in the RH strain, including 9 microneme proteins (MICs), 6 rhoptry proteins (ROPs), 2 dense granule proteins (GRAs), 5 surface proteins (SRSs), and 2 proteases (toxolysin 4 and subtilisin 1). In contrast, only 1 ROP, 1 GRA, and 1 SRS showed elevated expression in TgCtwh3 ESAs compared with RH strain ESAs. SRSs appeared in ESAs, likely due to the proteolytic shedding from the parasite20,30. Toxolysin 4 (TLN4) is a putative metalloprotease that is processed into multiple proteolytic fragments within the T. gondii secretory system31. Protease subtilisin 1 (SUB1) is essential for cell surface processing of micronemal adhesive protein complexes and efficient adhesion of tachyzoites32. Several proteins from non-secretory organelles also appeared in the ESAs (Supplementary Table S1) and were likely released from dead tachyzoites.
Table 1. T. gondii ESA proteins with different abundances in strains RH and TgCtwh3.
No. | ToxoDB IDa | Protein Name | Fold Changes (RH/TgCtwh3)b | Sequence Coverage (%) | Unique Peptides |
---|---|---|---|---|---|
1 | TGGT1_019450 | microneme protein MIC2 | 3.687 | 20.7 | 10 |
2 | TGGT1_125360 | MIC2-associated protein M2AP | 4.323 | 10.0 | 3 |
3 | TGGT1_121730 | microneme protein MIC3 | 5.259 | 21.2 | 5 |
4 | TGGT1_021130 | microneme protein MIC4 | 2.774 | 19.3 | 10 |
5 | TGGT1_029350 | microneme protein MIC6 | 3.072 | 12.6 | 4 |
6 | TGGT1_027570 | microneme protein MIC9 | 3.014 | 11.0 | 7 |
7 | TGGT1_102150 | microneme protein MIC10 | 1.733 | 23.2 | 5 |
8 | TGGT1_016150 | microneme protein MIC11 | 1.687 | 21.6 | 4 |
9 | TGGT1_060480 | microneme protein MIC17A | 9.806 | 16.8 | 4 |
10 | TGGT1_062250 | toxolysin TLN4 | 1.779 | 5.0 | 9 |
11 | TGGT1_016650 | subtilisin SUB1 | 5.344 | 8.2 | 4 |
12 | TGGT1_085550 | rhoptry protein ROP1 | 17.578 | 7.2 | 3 |
13 | TGGT1_042710 | rhoptry protein ROP5 | 2.496 | 8.9 | 4 |
14 | TGGT1_075470 | rhoptry protein ROP7 | 0.787 | 22.4 | 9 |
15 | TGGT1_123520 | rhoptry protein ROP15 | 1.334 | 21.6 | 6 |
16 | TGGT1_063760 | rhoptry protein ROP18 | 3.842 | 8.5 | 4 |
17 | TGGT1_031600 | rhoptry kinase family protein ROP40 | 1.994 | 20.0 | 9 |
18 | TGGT1_041290 | rhoptry neck protein RON8 | 2.904 | 8.5 | 22 |
19 | TGGT1_082670 | dense granule protein GRA3 | 5.811 | 10.4 | 2 |
20 | TGGT1_102940 | dense granule protein GRA9 | 0.614 | 18.9 | 5 |
21 | TGGT1_034740 | dense granule protein GRA12 | 1.360 | 22.7 | 9 |
22 | TGGT1_121850 | SAG-related sequence SRS17B | 2.356 | 27.4 | 6 |
23 | TGGT1_039470 | SAG-related sequence SRS25 | 3.342 | 11.5 | 2 |
24 | TGGT1_113990 | SAG-related sequence SRS29C (SRS2) | 1.359 | 12.6 | 4 |
25 | TGGT1_072740 | SAG-related sequence SRS35A | 0.232 | 22.1 | 3 |
26 | TGGT1_055870 | SAG-related sequence SRS51 (SRS3) | 6.591 | 8.3 | 4 |
27 | TGGT1_092760 | SAG-related sequence SRS52A | 2.481 | 14.5 | 3 |
aToxoDB release 8.0 (http://www.toxodb.org).
bSignificant differences (P < 0.05), Student’s t-test.
Gene Ontology (GO) annotation
GO annotation (http://www.geneontology.org/) was performed to better understand the biological functions of the 66 differentially expressed T. gondii ESA proteins. The proteins were classified based on biological processes, cellular components, and molecular function according to the GO database. Information from the GO database suggested that some of the 66 differentially expressed T. gondii ESA proteins may be important for virulence, including attachment to, and invasion of target cells.
Enrichment analyses of GO annotations were performed on proteins that were upregulated in T. gondii RH ESAs or TgCtwh3 ESAs. Functions involved in important biological processes, such as metabolic processes, cellular processes, and biological regulation, were significantly overrepresented in each T. gondii ESAs (Fig. 4). The majority of the highly expressed proteins in RH ESAs or TgCtwh3 ESAs originated from organelles or macromolecular complexes. However, upregulated proteins in the RH strain contained more membrane and extracellular proteins than the TgCtwh3 strain. Moreover, these differentially expressed proteins were associated with important molecular functions. Functions involved in binding and catalytic activity were found to be significantly overrepresented in each T. gondii strain. However, several functions, such as antioxidant activity, molecular transducer activity, and receptor activity, were significantly underrepresented in T. gondii TgCtwh3.
Protein-protein correlation of differentially expressed proteins in T. gondii ESAs
The exploration of protein-protein correlations is a new strategy to identify important functional nodes controlling crucial networks for parasite invasion and survival. A correlation analysis was conducted based on the Pearson’s correlation coefficient to select key functional nodes among several upregulated and downregulated proteins in T. gondii RH ESAs. Clear correlations (r > 0.6 or < −0.6, P < 0.01) could be visualized between MICs, ROPs, GRAs, or SRSs by Cytoscape33. A total of 17 secretory proteins were highly correlated with other proteins, including 7 MICs, 4 ROPs, 5 SRSs, and GRA12 (Fig. 5). This finding was indicative of the ability of these proteins to form complexes, or to interact during the attachment or invasion process of T. gondii. Among these proteins, MIC3 was an important functional node protein and was subsequently characterized.
Transcriptional analysis of five differentially expressed T. gondii ESA proteins
Rop1, Rop18, MIC3, MIC6 and GRA3 were selected for transcriptional analysis because they were >3-fold more abundant in the ESAs of strain RH than in strain TgCtwh3 and highly correlated with other proteins. Quantitative RT-PCR using gene-specific primers (Supplementary Table S2) showed that the mRNA of all five genes was >3-fold more abundant in strain RH than in TgCtwh3 (Fig. 6). This finding was consistent with the observed protein levels, suggesting that the corresponding genes were under transcriptional control.
Recombinant T. gondii MIC3 induces TNF-α secretion in macrophages
In our study, MIC3 was found to be an important functional node protein and >3-fold upregulated in RH compared with TgCtwh3 both at the protein and transcriptional levels. Previous results demonstrated that MIC3 could bind to the surface of host cells and aid initial parasite invasion34, but little is known about whether MIC3 is responsible for TNF-α production. Our aim was to evaluate whether pure T. gondii MIC3 protein was an important inducer of TNF-α secretion by mouse peritoneal macrophages. First, we determined the sequences of MIC3 from T. gondii RH and TgCtwh3 by sequencing. The amino acid sequences of MIC3 from T. gondii RH and TgCtwh3 are identical (Supplementary Fig. S4). To generate biologically meaningful results, we wanted to use the same amount of recombinant MIC3 as was present in the ESA preparations. iTRAQ proteomics measures only relative levels of proteins. The absolute amounts of MIC3 were measured using an enzyme linked immunosorbent assay (ELISA) with anti-MIC3 antibodies. The ESA preparations contained 10 μg/ml proteins. The ESA preparations from strains RH and TgCtwh3 contained 0.071 and 0.020 μg/ml MIC3 protein, respectively (Fig. 7A). Three-day treatment of mouse peritoneal macrophages with 0.071 or 0.020 μg/ml recombinant MIC3 resulted in the secretion of 415.71 ± 57.18 or 273.35 ± 33.40 pg/ml TNF-α, respectively (Fig. 7B). The ratio between the two values was approximately 1.5, as observed for the RH and TgCtwh3 ESA preparations in peritoneal macrophages (Fig. 1D). However, the amounts of secreted TNF-α were approximately only 30% of those obtained by treatment with ESA preparations.
To establish whether MIC3 is the determining factor in the induction of TNF-α, we performed immunoprecipitation (IP) to deplete MIC3 from ESAs (Fig. 7C). The results suggested that MIC3-depleted RH ESAs induced a much lower level of TNF-α (approximately 2/3) than RH ESAs (P < 0.001). These findings demonstrate that MIC3 is a dominant factor in the induction of TNF-α.
We measured the level of TNF-α secretion by splenocytes stimulated with different concentrations of MIC3 to further evaluate the role of MIC3 in this process. The levels of TNF-α in the experimental groups with MIC3 were significantly higher than those in OVA controls at 1 (145.82 ± 10.05 pg/ml vs. 7.88 ± 7.15 pg/ml, P < 0.001), 2 (230.66 ± 10.47 pg/ml vs. 0.14 ± 5.57 pg/ml, P < 0.001), 4 (490.05 ± 46.17 pg/ml vs. 1.43 ± 2.79 pg/ml, P < 0.001), and 8 μg/ml (850.99 ± 71.79 pg/ml vs. 1.92 ± 4.42 pg/ml, P < 0.001) (Fig. 7D). This result indicated that MIC3 was an effective inducer of TNF-α. During acute infection with T. gondii, TNF-α acts synergistically with IFN-γ, resulting in the elimination of intracellular pathogens35. However, MIC3 did not induce any IFN-γ secretion compared with OVA in splenocytes (Supplementary Fig. S5). We measured the level of TNF-α secretion by macrophages stimulated with MIC3 because TNF-α was first described as a factor secreted by macrophages that can induce intense tumour necrosis. The same result was observed in peritoneal macrophages stimulated with MIC3. Notably, the TNF-α levels were higher in the MIC3 groups than in the OVA controls at 1 (475.54 ± 64.98 pg/ml vs. 306.49 ± 15.27 pg/ml, P < 0.01), 2 (734.58 ± 49.13 pg/ml vs. 442.88 ± 18.48 pg/ml, P < 0.001), 4 (1136.67 ± 115.12 pg/ml vs. 477.40 ± 45.26 pg/ml, P < 0.001), and 8 μg/ml (1176.74 ± 149.07 pg/ml vs. 492.80 ± 47.30 pg/ml, P < 0.001) (Fig. 7E). These results showed that MIC3 induced TNF-α secretion in macrophages. In addition, clear morphological changes in peritoneal macrophages were observed after MIC3 stimulation (Supplementary Fig. S6). Round cells became elongated and firmly adherent after MIC3 stimulation. Thus, activated macrophages were dominant in the MIC3 group compared with the OVA group as shown by morphological changes typical of differentiation.
iNOS, IL-6, Arg-1, IL-10 and Fizz-1 mRNA expression levels precisely reflect the overall polarization status. Thus, the mRNA expression levels of the primary M1 and M2 polarization markers, iNOS, IL-6, Arg-1, IL-10 and Fizz-1, were evaluated in macrophages in our study. MIC3 stimulation increased both iNOS and Arg-1 expression compared with OVA (Fig. 7F). The overall polarization of macrophages shifted to M1 dominance after stimulation with 8 μg/ml MIC3 because the expression of iNOS significantly increased (>6-fold) and the expression of Arg-1, Fizz-1 and IL-10 showed no notable change (<2.5-fold). In addition, this increased iNOS expression was accompanied by a slight increase in the expression of IL-6 (>3-fold). Furthermore, we analysed the expression of selected cell surface markers, CD16/32 and CD206, to characterize peritoneal macrophage polarization (Fig. 7G). MIC3 stimulation elevated the percentage of CD16/32+ macrophages compared with OVA. In the 8 μg/ml MIC3 group, approximately 80% of the F4/80+CD11b+ cells were CD16/32+ macrophages. These results showed that MIC3 played an important role in the induction of macrophage polarization.
Discussion
T. gondii has attracted attention as a substantial public health risk in China, with a 7.9% seropositive rate in humans10. The Chinese 1 lineage is a dominant lineage from swine, cats, and humans in mainland China2. Clarifying the virulence discrepancy between Chinese 1 and Type I (very prevalent in North America and Europe) genotypes is essential to gain a better understanding of T. gondii isolates in the Chinese 1 genetic background. The T. gondii Chinese 1 TgCtwh3 strain is less virulent than the Western Type I RH strain according to mouse hazard ratio tests. We found that in C57BL/6 mice, the T. gondii strain TgCtwh3 induced less TNF-α production than strain RH (Fig. 1A). This finding was significant because TNF-α was believed to be an important defence against T. gondii infection and a powerful inducer of inflammation22,36. Special efforts were implemented to remove potential lipopolysaccharides (LPS) from the ESA preparations, which are potent TNF-α inducers. Next, we confirmed that the T. gondii ESA preparations induced TNF-α production in mouse splenocytes or peritoneal macrophages, similar to tachyzoites infection (Fig. 1C,D). Therefore, we hypothesized that the differential expression of one or more specific ESA proteins may be responsible for the difference in virulence between the two T. gondii strains.
Proteomic information for the Chinese 1 lineage is scarce and insufficient despite recent developments in this field. In the present work, we investigated the proteomic profiles from tachyzoite ESAs of two T. gondii lineages belonging to the Chinese 1 and Type I genotypes. The differentially expressed ESA proteins were compared using iTRAQ. A total of 27 proteins were identified, including 9 MICs, 7 ROPs, 3 GRAs, 6 SRSs, and 2 proteases. Among these proteins, Rop1, Rop18, MIC3, MIC6, and GRA3 were further confirmed to be highly expressed (>3-fold) in the RH strain both at the protein and mRNA levels. Several of these proteins, have been directly linked to the infection process by way of functions such as cell adhesion, or formation of the host parasitophorous vacuole (PV) that protects T. gondii from host cell defences. For example, ROP1 initially lines the vacuolar space but disappears as the vacuole matures, functioning as a penetration-enhancing factor19,20. Deletion of ROP18 resulted in complete attenuation of virulence in T. gondii South American strains37. MIC3 is the adhesive component of the MIC3/8 complex because it has a demonstrable host cell binding property, an NH2-terminal chitin binding (CB)-like (CBL) domain38. MIC6 of the MIC1/4/6 complex not only functions to anchor the adhesive complex to the membrane of the host cell but also acts as a “quality control” protein that is required to release the complex from a checkpoint located in the Golgi apparatus39. GRA3 has been shown to be important for the structure of the PV and nutrient acquisition for the parasite40. Previous studies have demonstrated that these five proteins played an important role in virulence. Thus, their upregulated expression in the RH strain contributes to the discrepancy in virulence between the RH and TgCtwh3 strains.
The release of TNF-α, which is a 157 amino acid cytokine, can be triggered by various molecules of microbial origin, of which the most active is bacterial LPS endotoxin41,42. However, under conditions that exclude any impact of contaminating endotoxin, a number of intracellular parasites, including the malarial parasites, Leishmania and Trypanosoma cruzi, could also induce the release of TNF-α43,44,45. As an intracellular pathogen, T. gondii can also induce TNF-α production22. Toxoplasmosis patients, especially those who develop ocular or cerebral toxoplasmosis, produced high levels of TNF-α22. In our study, the ESA preparations from T. gondii were comparable to those of live tachyzoites in terms of their ability to induce TNF-α. This result suggested that specific antigens from T. gondii ESAs might be responsible for TNF-α production.
Stimulation of TNF-α synthesis by T. gondii plays an important role in the regulation of the resistance mechanisms and pathologic effects induced by this organism. Nevertheless, little is known about the parasite molecules involved in this process. Previous studies have largely focused on glycosylphosphatidylinositols (GPIs) from T. gondii tachyzoites responsible for the induction of TNF-α in macrophages46,47,48. In our study, MIC3 was shown for the first time to be the relevant parasite molecule responsible for TNF-α induction (Fig. 7). MIC3 is known to be the adhesive component of the MIC3/8 complex38, and it has been proposed as a DNA vaccine candidate against toxoplasmosis49. These data highlight additional directions of study to understand the roles of MICs during infection. MIC3 not only is an exclusive protein in the invasion of T. gondii but also mediates the immunopathogenesis of toxoplasmosis. Hence, we imagine that MIC3 plays multiple roles during the entire course of toxoplasmosis. The MIC3-derived adhesin function may aid initial parasite invasion. Later, secreted MIC3 induces TNF-α secretion, reducing the proliferation of T. gondii tachyzoites; however, the accumulation of TNF-α also aggravated inflammation via T-cell-mediated tissue damage36.
MIC3 and other TNF-α-inducing molecules may have potential uses as immunomodulators. In contrast to LPS and total T. gondii ESAs, MIC3 triggers TNF-α synthesis without the potential side effects of simultaneous IFN-γ production (Fig. S5). TNF-α plays several therapeutic roles within the body, including immunostimulation, resistance to tumors, and sleep regulation26,50. TNF-α is also an important mediator of resistance against infectious diseases22,51,52,53,54,55. For example, in experimental leishmaniasis, insufficient TNF-α is associated with progressive disease and death53. In neosporiasis, exogenous TNF-α reduced Neospora caninum tachyzoites numbers in cultures in a dose-dependent manner54. In cerebral toxoplasmosis, TNF-α acts synergistically with IFN-γ, resulting in an antiparasitic mechanism in brain cells22.
However, other ESA proteins that were differentially expressed between strains RH and TgCtwh3 also played their roles because these proteins interact with each other, as shown by the correlation plot (Fig. 5). All differentially expressed ESA proteins should therefore be investigated as possible targets for the prevention of T. gondii infection, which causes serious health problems, including birth defects, worldwide. In addition to identifying MIC3 as a potent inducer of TNF-α production, this study also provides a vast resource of protein information specifically for the virulent, non-cystogenic T. gondii Chinese 1 TgCtwh3.
Methods
Preparation of ESAs from T. gondii
T. gondii RH and TgCtwh3 tachyzoites were preserved in liquid nitrogen and resuscitated in C57BL/6 mice by intraperitoneal inoculation. This study received approval from the Animal Ethics Committee of Nanjing Medical University, and all animal experiments were conducted in accordance with the approved guidelines (Permit Number: NJMU/IACUC 1403048). ESAs were prepared as described previously with some modifications56. Tachyzoites harvested from peritoneal fluid were filtered through a 3 μm pore size track-etched membrane (Shanghai Nengthink Filtration Technology Co. Ltd., Shanghai, China) to remove host cell debris. After filtration, more than 95% of the tachyzoites were confirmed to be viable using trypan blue (Gibco BRL, Gaithersburg, MD, USA). Then, 1 × 108 tachyzoites were incubated in 10 ml of RPMI 1640 medium (Gibco BRL) under mild agitation for 3 h at 37 °C. The samples were then centrifuged at 1,000 × g for 10 min at 4 °C. The ESA-containing supernatant was diluted with PBS and concentrated to 2 ml using an Amicon Ultra-15 centrifugal filter unit (5000 MWCO, Millipore, Billerica, MA, USA). Endotoxin was then removed using AffinityPak Detoxi-Gel Endotoxin Removing Gel (Thermo, Fairlawn, OH, USA) and the ESA-containing fluid was filtered through a 0.22 μm filter (Millipore). Endotoxin levels in RH ESAs and TgCtwh3 ESAs were < 0.1 EU/mg protein, as determined by a Limulus assay (Xiamen Limulus Reagent Co. Ltd., Xiamen, China). The ESA samples were then treated with dithiothreitol as described in Supplementary Protocol 1. Two independent biological replicates were performed for each strain. Protein concentrations were assayed using the Bradford method.
ESA protein digestion and iTRAQ labelling
The protein from the previous step was resuspended in digestion buffer (100 mM TEAB, 0.05% SDS) to a final concentration of 1 mg/ml. Equal aliquots (100 μg) from each sample were digested with trypsin (Sigma; 1:20 w/w added at 0 and 4 h) overnight at 37 °C and dried using a vacuum centrifuge.
From each T. gondii strain, two samples from separately propagated tachyzoites (biological replicates) were labelled using different isobaric tags (RH, 114- and 118-tags; TgCtwh3, 119- and 121-tags). The procedure is outlined in Supplementary Protocol 2 in the Supplementary Information.
LC-MS/MS analysis
Each fraction was resuspended in buffer A (5% ACN, 0.1% FA) and centrifuged at 20, 000 × g for 10 min. The final concentration of peptide in the supernatant was approximately 0.5 μg/μl. LC-MS/MS was performed using a Triple TOF 5600 System (AB SCIEX, Framingham, MA, USA) coupled to an LC-20AD nanoHPLC (Shimadzu). The supernatant (5 μl) was loaded on the nanoHPLC by the autosampler onto a 2 cm C18 trap column. The samples were loaded at 8 μl/min for 4 min. The 60 min gradient was subsequently run at 300 nl/min, beginning with 5% buffer B (95% ACN, 0.1% FA) for 5 min, 5–35% buffer B for 35 min, followed by a 5-min linear gradient to 60%, a 2-min linear gradient to 80%, maintenance at 80% with buffer B for 2 min, and finally replacement with 5% Buffer B for 10 min. Data acquisition was performed using a Triple TOF 5600 System fitted with a Nanospray III source (AB SCIEX) and a pulled quartz tip as the emitter (New Objectives, Woburn, MA, USA). The procedure is outlined in Supplementary Protocol 3.
Proteomic data analysis
The resulting MS/MS spectra were searched against the composite database of T. gondii GT1 and IPI_mouse available at ToxoDB57 and the European Bioinformatics Institute (EBI). The search parameters are presented in Supplementary Protocol 4.
Functional category analysis was performed using Blast2GO software (http://www.geneontology.org). The heat map was generated using MultiExperimentViewer (version 4.8.1) to visualize differences in protein expression58. The protein-protein correlation network was generated using Pearson’s correlation coefficient and visualized with Cytoscape software version 2.8.333. The Pearson’s correlation coefficient for differentially expressed ESA proteins was calculated using R, and its significance was tested (r > 0.6 or < −0.6, P < 0.01).
Real-time qRT-PCR
The mRNA levels in T. gondii or in mouse peritoneal macrophages were determined by qRT-PCR. RNA was extracted using TRIzol reagent (Invitrogen, San Diego, CA, USA). Genomic DNA was removed using DNase I (Thermo Fisher Scientific Fermentas, Vilnius, Lithuania) according to the manufacturer’s instructions. First-strand cDNA was synthesized from 4 μg total RNA using a RevertAid™ First Strand cDNA Synthesis Kit (Thermo Fisher Scientific Fermentas). Semi-quantitative RT-PCR was performed using SYBR Green PCR master mix (Applied Biosystems) and an ABI Prism 7300 sequence detection system (Applied Biosystems). Gene-specific primers were designed using Primer Premier 5.0, and the sequences of the primer pairs are listed in Supplementary Table S2. Changes in the fluorescence of SYBR Green I were monitored by the system software for every cycle. The threshold cycle and melting curves were measured automatically. Data are presented as the means ± S.D. from six independent measurements. GAPDH served as the internal control. The relative expression level of each gene was calculated using the 2−(△△Ct) method.
In vivo TNF-α production in mice after T. gondii Infection and quantification of T. gondii burden
T. gondii tachyzoites (1 × 106) were intraperitoneally inoculated into groups of six-week-old C57BL/6 mice, which were purchased from the Model Animal Research Center of Nanjing University (Nanjing, China). The mice were sacrificed after 3 days. Serum levels of TNF-α were measured by ELISA according to the instructions of the manufacturer (eBioscience, San Diego, CA, USA). Spleens were harvested to assess the parasite burden. The procedure is outlined in Supplementary Protocol 5. All animal experiment protocols were approved by the Animal Ethics Committee of Nanjing Medical University. All experiments were performed in accordance with the approved guidelines.
In vitro TNF-α production by mouse splenocytes in response to T. gondii tachyzoites
Splenocytes were harvested from six-week-old C57BL/6 mice. Next, RH or TgCtwh3 tachyzoites (1 × 106) were inoculated into splenocytes (1 × 106) in vitro. Supernatants were collected after 72 h and frozen at −80 °C for TNF-α determination.
In vitro TNF-α production by mouse splenocytes or macrophages in response to T. gondii ESA or MIC3 stimulation
T. gondii ESAs or active T. gondii MIC3 protein (Abcam, Cambridge, UK) were treated with AffinityPak Detoxi-Gel Endotoxin Removing Gel (Thermo) to achieve an endotoxin level < 0.1 EU/mg. Splenocytes or peritoneal macrophages were harvested from six-week-old C57BL/6 mice. The ESAs or MIC3 protein were then used to stimulate splenocytes (2 × 106) or peritoneal macrophages (1 × 106) in vitro. Supernatants were collected after 72 h and frozen at −80 °C for TNF-α determination. Peritoneal macrophages were also harvested for qRT-PCR analysis. The morphology of peritoneal macrophages was analysed using a phase contrast microscope (Olympus, Tokyo, Japan). The procedure applied for the in vitro treatment of peritoneal macrophage is outlined in Supplementary Protocol 6.
All data are presented as the means ± S.D. from six independent experiments. Statistical tests to generate P-values are indicated in the corresponding figure legends.
Concentration of MIC3 in T. gondii ESAs
ELISA was performed to quantitate MIC3 in T. gondii RH and TgCtwh3 ESAs. Serial dilutions of the active T. gondii MIC3 protein fragment were used as the standard. Ten micrograms of each ESA was immobilized and probed with mouse anti-T. gondii MIC3 antibodies (GeneTex, San Antonio, Texas, USA). Horseradish peroxidase (HRP)-labelled goat anti-mouse IgG (Santa Cruz Biotechnology, Santa Cruz, CA, USA) was used for detection. The plates were washed between each step to remove unbound antibodies. After the final wash, the plates were developed using tetramethylbenzidine and recorded using a Synergy HT Microplate Reader (BioTek, Winooski, VT, USA).
Immunoprecipitation (IP) of MIC3 from ESAs
The IP of MIC3 from ESAs was performed as described previously with some modification59. For a single IP, 20 μl mouse monoclonal antibody to T. gondii MIC3 (anti-MIC3 mAb, GeneTex) was incubated with 200 μl protein G-agarose suspension (Sigma-Aldrich, St. Louis, MO, USA) at 4 °C for 3 h. Next, anti-MIC3 mAb conjugated to the protein G-agarose suspension was collected by centrifugation, mixed with ESAs (200 μg) and incubated with mixing at 4 °C for 3 h. Finally, the protein G-agarose was removed by centrifugation. The depletion of MIC3 from ESA was analysed by ELISA. Protein concentrations were assayed using the Bradford method. Equal amounts of ESAs and MIC3-depleted ESAs were loaded.
Flow cytometry
To evaluate macrophage polarization, peritoneal macrophages from each mouse were stimulated with RH ESAs, TgCtwh3 ESAs, MIC3 or OVA in complete RPMI 1640 medium for 72 h at 37 °C in 5% CO2. After 72 h, the cells were collected and incubated with anti-CD16/32 blocking antibody (eBioscience) at 4 °C for 15 min. For purity analysis, the cells were incubated with PE-conjugated antibody against mouse F4/80 and PerCP-Cy5.5-conjugated antibody against mouse CD11b (BioLegend, San Diego, CA, USA). For M1 and M2 surface marker analysis, the cells were incubated with FITC-labelled anti-mouse CD16/32, APC-labelled anti-mouse CD206, and FITC- or APC- conjugated rat IgG2a isotype antibodies (all from BioLegend). The samples were then evaluated using a FACSVerse flow cytometer (BD Biosciences, San Jose, CA, USA) and analysed using FlowJo (Tree Star, Ashland, OR, USA).
Additional Information
How to cite this article: Qiu, J. et al. Identification of a TNF-α inducer MIC3 originating from the microneme of non-cystogenic, virulent Toxoplasma gondii. Sci. Rep. 6, 39407; doi: 10.1038/srep39407 (2016).
Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Material
Acknowledgments
We thank Dr. Tobias Kieser for helpful discussions and critical reading of our manuscript. This work received financial supports from the Specialized Research Fund for the Doctoral Program of Higher Education of China (No. 20133234110003), the Natural Science Foundation of Jiangsu Province, China (No. BK20161032), and the Natural Science Fund of the Jiangsu Higher Education Institutions of China (No. 13KJB310004). This work was also partly supported by the National Basic Research Program of China (973 Program, No. 2010CB530001).
Footnotes
Author Contributions J.F.Q. conceived the project, designed research, performed experiments, analysed the data and wrote the manuscript. L.J.W., R.Z. and K.G. performed cell and animal experiments. H.F.G., X.J.L., J.F.L. and D.L.K. analysed proteomics data. Y.W. designed research, supervised the study and wrote the manuscript. All authors involved in writing and revising the manuscript.
References
- Weiss L. M. & Dubey J. P. Toxoplasmosis: A history of clinical observations. International journal for parasitology 39, 895–901 (2009). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wang L. et al. Genotypes and mouse virulence of Toxoplasma gondii isolates from animals and humans in China. Plos One 8, e53483 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Li M. et al. Phylogeny and virulence divergency analyses of Toxoplasma gondii isolates from China. Parasite Vector 7, 133 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Cohen A. M., Rumpel K., Coombs G. H. & Wastling J. M. Characterisation of global protein expression by two-dimensional electrophoresis and mass spectrometry: proteomics of Toxoplasma gondii. International journal for parasitology 32, 39–51 (2002). [DOI] [PubMed] [Google Scholar]
- Xia D. et al. The proteome of Toxoplasma gondii: integration with the genome provides novel insights into gene expression and annotation. Genome Biol 9, R116 (2008). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Dybas J. M. et al. Computational analysis and experimental validation of gene predictions in Toxoplasma gondii. Plos One 3, e3899 (2008). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Weiss L. M., Fiser A., Angeletti R. H. & Kim K. Toxoplasma gondii proteomics. Expert review of proteomics 6, 303–313 (2009). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Zhou H. Y. et al. Differential proteomic profiles from distinct Toxoplasma gondii strains revealed by 2D-difference gel electrophoresis. Exp Parasitol 133, 376–382 (2013). [DOI] [PubMed] [Google Scholar]
- Doliwa C. et al. Identification of differentially expressed proteins in sulfadiazine resistant and sensitive strains of Toxoplasma gondii using difference-gel electrophoresis (DIGE). Int J Parasitol-Drug 3, 35–44 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Coordinating Office of the National Survey on the Important Human Parasitic, D. A national survey on current status of the important parasitic diseases in human population. Chinese journal of parasitology & parasitic diseases 23, 332–340 (2005). [PubMed] [Google Scholar]
- Wang H. et al. Prevalence and genotypes of Toxoplasma gondii in pork from retail meat stores in Eastern China. Int J Food Microbiol 157, 393–397 (2012). [DOI] [PubMed] [Google Scholar]
- Zhou D. H. et al. Comparative proteomic analysis of different Toxoplasma gondii genotypes by two-dimensional fluorescence difference gel electrophoresis combined with mass spectrometry. Electrophoresis 35, 533–545 (2014). [DOI] [PubMed] [Google Scholar]
- Hughes H. P. & van Knapen F. Characterisation of a secretory antigen from Toxoplasma gondii and its role in circulating antigen production. International journal for parasitology 12, 433–437 (1982). [DOI] [PubMed] [Google Scholar]
- Decoster A., Darcy F. & Capron A. Recognition of Toxoplasma gondii excreted and secreted antigens by human sera from acquired and congenital toxoplasmosis: identification of markers of acute and chronic infection. Clinical and experimental immunology 73, 376–382 (1988). [PMC free article] [PubMed] [Google Scholar]
- Cesbron-Delauw M. F. & Capron A. Excreted/secreted antigens of Toxoplasma gondii–their origin and role in the host-parasite interaction. Research in immunology 144, 41–44 (1993). [DOI] [PubMed] [Google Scholar]
- Prigione I. et al. T cell clones raised from chronically infected healthy humans by stimulation with Toxoplasma gondii excretory-secretory antigens cross-react with live tachyzoites: characterization of the fine antigenic specificity of the clones and implications for vaccine development. Journal of immunology 164, 3741–3748 (2000). [DOI] [PubMed] [Google Scholar]
- Zenner L. et al. Protective immunity in the rat model of congenital toxoplasmosis and the potential of excreted-secreted antigens as vaccine components. Parasite immunology 21, 261–272 (1999). [DOI] [PubMed] [Google Scholar]
- Costa-Silva T. A., Borges M. M., Galhardo C. S. & Pereira-Chioccola V. L. Immunization with excreted/secreted proteins in AS/n mice activating cellular and humoral response against Toxoplasma gondii infection. Acta Trop 124, 203–209 (2012). [DOI] [PubMed] [Google Scholar]
- Carruthers V. B. & Boothroyd J. C. Pulling together: an integrated model of Toxoplasma cell invasion. Curr Opin Microbiol 10, 82–89 (2007). [DOI] [PubMed] [Google Scholar]
- Zhou X. W. et al. The opportunistic pathogen Toxoplasma gondii deploys a diverse legion of invasion and survival proteins. The Journal of biological chemistry 280, 34233–34244 (2005). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Grimwood J. & Smith J. E. Toxoplasma gondii: the role of parasite surface and secreted proteins in host cell invasion. International journal for parasitology 26, 169–173 (1996). [DOI] [PubMed] [Google Scholar]
- Meira C. S. et al. Cerebral and ocular toxoplasmosis related with IFN-gamma, TNF-alpha, and IL-10 levels. Front Microbiol 5, 492 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Jebbari H., Roberts C. W., Ferguson D. J., Bluethmann H. & Alexander J. A protective role for IL-6 during early infection with Toxoplasma gondii. Parasite immunology 20, 231–239 (1998). [DOI] [PubMed] [Google Scholar]
- Kong L. et al. Polarization of macrophages induced by Toxoplasma gondii and its impact on abnormal pregnancy in rats. Acta Trop 143, 1–7 (2015). [DOI] [PubMed] [Google Scholar]
- Cerede O. et al. Synergistic role of micronemal proteins in Toxoplasma gondii virulence. J Exp Med 201, 453–463 (2005). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Aggarwal B. B. Signalling pathways of the TNF superfamily: a double-edged sword. Nature reviews. Immunology 3, 745–756 (2003). [DOI] [PubMed] [Google Scholar]
- Murray P. J. & Wynn T. A. Protective and pathogenic functions of macrophage subsets. Nature reviews. Immunology 11, 723–737 (2011). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Cai Y., Chen H., Jin L., You Y. & Shen J. STAT3-dependent transactivation of miRNA genes following Toxoplasma gondii infection in macrophage. Parasit Vectors 6, 356 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Liu T. et al. Trophoblast apoptosis through polarization of macrophages induced by Chinese Toxoplasma gondii isolates with different virulence in pregnant mice. Parasitology research 112, 3019–3027 (2013). [DOI] [PubMed] [Google Scholar]
- Pollo-Oliveira L. et al. Unravelling the Neospora caninum secretome through the secreted fraction (ESA) and quantification of the discharged tachyzoite using high-resolution mass spectrometry-based proteomics. Parasite Vector 6, 335 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Laliberte J. & Carruthers V. B. Toxoplasma gondii toxolysin 4 is an extensively processed putative metalloproteinase secreted from micronemes. Molecular and biochemical parasitology 177, 49–56 (2011). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lagal V. et al. Toxoplasma gondii protease TgSUB1 is required for cell surface processing of micronemal adhesive complexes and efficient adhesion of tachyzoites. Cell Microbiol 12, 1792–1808 (2010). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Saito R. et al. A travel guide to Cytoscape plugins. Nat Methods 9, 1069–1076 (2012). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Garcia-Reguet N. et al. The microneme protein MIC3 of Toxoplasma gondii is a secretory adhesin that binds to both the surface of the host cells and the surface of the parasite. Cell Microbiol 2, 353–364 (2000). [DOI] [PubMed] [Google Scholar]
- Jin P. et al. Interferon-gamma and tumor necrosis factor-alpha polarize bone marrow stromal cells uniformly to a Th1 phenotype. Scientific reports 6, 26345 (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kalliolias G. D. & Ivashkiv L. B. TNF biology, pathogenic mechanisms and emerging therapeutic strategies. Nature reviews. Rheumatology 12, 49–62 (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Behnke M. S. et al. Rhoptry proteins ROP5 and ROP18 are major murine virulence factors in genetically divergent South American strains of Toxoplasma gondii. Plos Genet 11, e1005434 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Cerede O., Dubremetz J. F., Bout D. & Lebrun M. The Toxoplasma gondii protein MIC3 requires pro-peptide cleavage and dimerization to function as adhesin. Embo J 21, 2526–2536 (2002). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Reiss M. et al. Identification and characterization of an escorter for two secretory adhesins in Toxoplasma gondii. J Cell Biol 152, 563–578 (2001). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Mercier C., Adjogble K. D., Daubener W. & Delauw M. F. Dense granules: are they key organelles to help understand the parasitophorous vacuole of all apicomplexa parasites? International journal for parasitology 35, 829–849 (2005). [DOI] [PubMed] [Google Scholar]
- Carswell E. A. et al. An endotoxin-induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci USA 72, 3666–3670 (1975). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Qin X. et al. Micheliolide inhibits LPS-induced inflammatory response and protects mice from LPS challenge. Scientific reports 6, 23240 (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bate C. A., Taverne J. & Playfair J. H. Malarial parasites induce TNF production by macrophages. Immunology 64, 227–231 (1988). [PMC free article] [PubMed] [Google Scholar]
- Carvalho L. P., Pearce E. J. & Scott P. Functional dichotomy of dendritic cells following interaction with Leishmania braziliensis: infected cells produce high levels of TNF-alpha, whereas bystander dendritic cells are activated to promote T cell responses. Journal of immunology 181, 6473–6480 (2008). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Montalvao F. et al. Apoptotic lymphocytes treated with IgG from Trypanosoma cruzi infection increase TNF-alpha secretion and reduce parasite replication in macrophages. European journal of immunology 40, 417–425 (2010). [DOI] [PubMed] [Google Scholar]
- Debierre-Grockiego F. et al. Activation of TLR2 and TLR4 by glycosylphosphatidylinositols derived from Toxoplasma gondii. Journal of immunology 179, 1129–1137 (2007). [DOI] [PubMed] [Google Scholar]
- Debierre-Grockiego F. et al. Roles of glycosylphosphatidylinositols of Toxoplasma gondii. Induction of tumor necrosis factor-alpha production in macrophages. The Journal of biological chemistry 278, 32987–32993 (2003). [DOI] [PubMed] [Google Scholar]
- Tomavo S., Schwarz R. T. & Dubremetz J. F. Evidence for glycosyl-phosphatidylinositol anchoring of Toxoplasma gondii major surface antigens. Molecular and cellular biology 9, 4576–4580 (1989). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ismael A. B., Sekkai D., Collin C., Bout D. & Mevelec M. N. The MIC3 gene of Toxoplasma gondii is a novel potent vaccine candidate against toxoplasmosis. Infection and immunity 71, 6222–6228 (2003). [DOI] [PMC free article] [PubMed] [Google Scholar]
- van Horssen R., Ten Hagen T. L. & Eggermont A. M. TNF-alpha in cancer treatment: molecular insights, antitumor effects, and clinical utility. The oncologist 11, 397–408 (2006). [DOI] [PubMed] [Google Scholar]
- Segueni N. et al. Innate myeloid cell TNFR1 mediates first line defence against primary Mycobacterium tuberculosis infection. Scientific reports 6, 22454 (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wang W. et al. Convergent transcription of interferon-stimulated genes by TNF-alpha and IFN-alpha augments antiviral activity against HCV and HEV. Scientific reports 6, 25482 (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fromm P. D., Kling J. C., Remke A., Bogdan C. & Korner H. Fatal leishmaniasis in the absence of TNF despite a strong Th1 response. Front Microbiol 6, 1520 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Jesus E. E. et al. Effects of IFN-gamma, TNF-alpha, IL-10 and TGF-beta on Neospora caninum infection in rat glial cells. Exp Parasitol 133, 269–274 (2013). [DOI] [PubMed] [Google Scholar]
- Allie N. et al. Prominent role for T cell-derived tumour necrosis factor for sustained control of Mycobacterium tuberculosis infection. Scientific reports 3, 1809 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ge Y. Y. et al. Natural killer cell intrinsic toll-like receptor MyD88 signaling contributes to IL-12-dependent IFN-gamma production by mice during infection with Toxoplasma gondii. International journal for parasitology 44, 475–484 (2014). [DOI] [PubMed] [Google Scholar]
- Gajria B. et al. ToxoDB: an integrated Toxoplasma gondii database resource. Nucleic acids research 36, D553–D556 (2008). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Saeed A. I. et al. TM4: a free, open-source system for microarray data management and analysis. BioTechniques 34, 374–378 (2003). [DOI] [PubMed] [Google Scholar]
- Zhou S. et al. Heat shock protein 60 in eggs specifically induces Tregs and reduces liver immunopathology in mice with Schistosomiasis japonica. Plos One 10, e0139133 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.